Pharmahungary Group as a Hungarian SME is ready to join Horizon Europe grant applications with innovative preclinical and clinical R&D services.
Update from COVIRNA project – European Health Management Association session
Péter Ferdinandy, MD, PhD, MBA, Founder & CEO of Pharmahungary Group has been noticed as ‘Highly Cited Researcher’ for the 4th time
Pharmahungary Group Clinical Director emphasized the importance of the new European Union legislation on clinical trials during her lecture
National Heart Program: successfully closed – significant advances
Akadálymentesítés eszközei